Cat.#: ACPP-1218
| Despition | Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1114 | Recombinant Human NCAM1 Protein (6×His Tag) (AC1114) | 50 µg | inquiry |
| ACPP-1342 | ORP150 Blocking Peptide (AC1342) | 250 µg | inquiry |
| ACPP-1840 | Human ALDH1A1 Protein (AC1840) | 5 µg | inquiry |
| ACPP-1164 | Synthetic Nanodisc Human GRPR Protein (AC1164) | 10 µg | inquiry |
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg | inquiry |
| ACPP-1717 | Mouse LIF Protein (AC1717) | 3 x 2 µg | inquiry |
| ACPP-1184 | MSX1 Blocking Peptide (AC1184) | 250 µg | inquiry |
| ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
| ACPP-1516 | Human Insulin Protein, Yeast (AC1516) | 2 mg | inquiry |
| ACPP-1229 | Mouse Leptin Protein (AC1229) | 200 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.